These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17425288)

  • 1. Structural features of target RNA molecules greatly modulate the cleavage efficiency of trans-acting delta ribozymes.
    Swiatkowska A; Dutkiewicz M; Ciesiołka J
    Biochemistry; 2007 May; 46(18):5523-33. PubMed ID: 17425288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of circular permutation on the cis-cleavage reaction of a hepatitis delta virus ribozyme: application to trans-acting ribozyme design.
    Lai YC; Lee JY; Liu HJ; Lin JY; Wu HN
    Biochemistry; 1996 Jan; 35(1):124-31. PubMed ID: 8555165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis delta virus ribozymes fold to generate a solvent-inaccessible core with essential nucleotides near the cleavage site phosphate.
    Rosenstein SP; Been MD
    Biochemistry; 1996 Sep; 35(35):11403-13. PubMed ID: 8784196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of antigenomic hepatitis delta virus ribozyme cis- and trans- analogs.
    Savochkina L; Alekseenkova V; Belyanko T; Lukin M; Beabealashvilli R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):935-42. PubMed ID: 15560085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots.
    Chadalavada DM; Senchak SE; Bevilacqua PC
    J Mol Biol; 2002 Apr; 317(4):559-75. PubMed ID: 11955009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic core structure of the trans-acting HDV ribozyme is subtly influenced by sequence variation outside the core.
    Gondert ME; Tinsley RA; Rueda D; Walter NG
    Biochemistry; 2006 Jun; 45(24):7563-73. PubMed ID: 16768452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between RNA molecules of a two-componet trans-analog of antigenomic HDV-ribozyme].
    Alekseenkova VA; Belianko TI; Lukin MA; Savochkina LP; Bibilashvili RSh
    Mol Biol (Mosk); 2006; 40(1):90-9. PubMed ID: 16523696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-acting hepatitis delta virus ribozyme: catalytic core and global structure are dependent on the 5' substrate sequence.
    Jeong S; Sefcikova J; Tinsley RA; Rueda D; Walter NG
    Biochemistry; 2003 Jul; 42(25):7727-40. PubMed ID: 12820882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental evidence for the secondary structure of the hepatitis delta virus ribozyme.
    Perrotta AT; Rosenstein SP; Been MD
    Prog Clin Biol Res; 1993; 382():69-77. PubMed ID: 8502719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential folding of the genomic ribozyme of the hepatitis delta virus: structural analysis of RNA transcription intermediates.
    Matysiak M; Wrzesinski J; Ciesiołka J
    J Mol Biol; 1999 Aug; 291(2):283-94. PubMed ID: 10438621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conformational switch controls hepatitis delta virus ribozyme catalysis.
    Ke A; Zhou K; Ding F; Cate JH; Doudna JA
    Nature; 2004 May; 429(6988):201-5. PubMed ID: 15141216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an HDV ribozyme which consists of three RNA oligomer strands.
    Sakamoto T; Kuwabara T; Tanaka Y; Kurihara Y; Katahira M; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):131-2. PubMed ID: 8841587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic cleavage of cis- and trans-acting antigenomic delta ribozymes in the presence of various divalent metal ions.
    Wrzesinski J; Legiewicz M; Smólska B; Ciesiolka J
    Nucleic Acids Res; 2001 Nov; 29(21):4482-92. PubMed ID: 11691936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A kinetic model of the cleavage of permutational variants of the antigenomic HDV-ribozyme].
    Alekseenkova VA; Belianko TI; Timofeeva AV; Savochkina LP; Heumann H; Bibilashvili RSh
    Mol Biol (Mosk); 2001; 35(5):879-99. PubMed ID: 11605542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity correlation for an HDV ribozyme composed of three RNA strands.
    Tanaka Y; Sakamoto T; Sasa K; Kuwabara T; Kim MH; Kurihara Y; Katahira M; Uesugi S
    Nucleic Acids Symp Ser; 1997; (37):309-10. PubMed ID: 9586123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.